These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Laboratory studies on the Russian BCG vaccine and comparison with th Polish vaccine prepared from the Brazilian substrain]. Buraczewska M, Paklerska-Pobratyn H, Pichula K. Gruzlica; 1967 Jul; 35(7):609-18. PubMed ID: 6078562 [No Abstract] [Full Text] [Related]
5. Comparison of the BCG vaccine produced in Poland and BCG vaccines produced from BCG substrains of various origin. Buraczewska M, Kurylowicz W, Paklerska-Pobratyn H. Pol Med J; 1966 Jul; 5(1):95-102. PubMed ID: 5935446 [No Abstract] [Full Text] [Related]
6. [Laboratory characteristics of BCG vaccine (from Brasilian and French substrains) produced in Poland and of the original Soviet vaccine]. Buraczewska M, Paklerska-Pobratyn H, Pichula K. Pediatr Pol; 1969 Dec; 44(12):1469-76. PubMed ID: 5371124 [No Abstract] [Full Text] [Related]
7. [Comparison of biological properties of BCG vaccines used in Poland 1964-1968]. Buraczewska M, Paklerska-Pobratyn H, Pichula K. Gruzlica; 1969 Oct; 37(10):901-6. PubMed ID: 5366981 [No Abstract] [Full Text] [Related]
8. Protective value of BCG vaccine. Udani PM. Indian Pediatr; 1982 Sep; 19(9):739-52. PubMed ID: 6984429 [No Abstract] [Full Text] [Related]
10. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A. Sugawara I, Udagawa T, Taniyama T. Tuberculosis (Edinb); 2007 Mar; 87(2):94-101. PubMed ID: 16815096 [Abstract] [Full Text] [Related]
11. [On some experimental aspects of antituberculosis vaccination with BCG]. Di Perna A, Ciaccia A, Rabinovici A. Lotta Tuberc; 1967 Mar; 37(3):Suppl:187-203. PubMed ID: 5252289 [No Abstract] [Full Text] [Related]